Biblio

Export 3292 results:
Author Title [ Type(Asc)] Year
Journal Article
C. Babiloni, Noce, G., Di Bonaventura, C., Lizio, R., Eldellaa, A., Tucci, F., Salamone, E. M., Ferri, R., Soricelli, A., Nobili, F., Famá, F., Arnaldi, D., Palma, E., Cifelli, P., Marizzoni, M., Stocchi, F., Bruno, G., Di Gennaro, G., Frisoni, G. B., and Del Percio, C., “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
H. Ramzaoui, Faure, S., and Spotorno, S., “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
C. Vakalopoulos, “Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.”, J Alzheimers Dis, vol. 60, no. 3, pp. 859-866, 2017.
D. Leger, Elbaz, M., Dubois, A., Rio, S., Mezghiche, H., Carita, P., Stemmelin, J., and Strauss, M., “Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 55, no. 1, pp. 321-331, 2017.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
F. El Gaamouch, Jing, P., Xia, J., and Cai, D., “Alzheimer's Disease Risk Genes and Lipid Regulators.”, J Alzheimers Dis, vol. 53, no. 1, pp. 15-29, 2016.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., “Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.”, Neuron, vol. 78, no. 4, pp. 631-43, 2013.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., “Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.”, J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
A. S. Buchman, Leurgans, S. E., Kim, N., Agrawal, S., Oveisgharan, S., Zammit, A. R., VanderHorst, V., Nag, S., and Bennett, D. A., “Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.”, J Alzheimers Dis, vol. 96, no. 2, pp. 563-578, 2023.
G. Forloni and Balducci, C., “Alzheimer's Disease, Oligomers, and Inflammation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1261-1276, 2018.
Q. - X. Li, Villemagne, V. L., Doecke, J. D., Rembach, A., Sarros, S., Varghese, S., McGlade, A., Laughton, K. M., Pertile, K. K., Fowler, C. J., Rumble, R. L., Trounson, B. O., Taddei, K., Rainey-Smith, S. R., Laws, S. M., Robertson, J. S., Evered, L. A., Silbert, B., Ellis, K. A., Rowe, C. C., S Macaulay, L., Darby, D., Martins, R. N., Ames, D., Masters, C. L., and Collins, S., “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., “Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.”, Neurology, vol. 74, no. 3, pp. 201-9, 2010.
R. H. Swerdlow, “The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview.”, J Alzheimers Dis, vol. 92, no. 3, pp. 751-768, 2023.
K. C Kim, Lee, Y. Rui, Ong, L., Gold, M., Kalali, A., and Sarkar, J., “Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.”, J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
I. E. Vega, Cabrera, L. Y., Wygant, C. M., Velez-Ortiz, D., and Counts, S. E., “Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health.”, J Alzheimers Dis, vol. 58, no. 4, pp. 979-992, 2017.
A. Watad, Bragazzi, N. L., Tiosano, S., Yavne, Y., Comaneshter, D., Cohen, A. D., and Amital, H., “Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
A. Aljassabi, Zieneldien, T., Kim, J., Regmi, D., and Cao, C., “Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
L. Shen, Liu, L., and Ji, H. - F., “Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.”, J Alzheimers Dis, vol. 56, no. 1, pp. 385-390, 2017.
J. B. Vasquez, Simpson, J. F., Harpole, R., and Estus, S., “Alzheimer's Disease Genetics and ABCA7 Splicing.”, J Alzheimers Dis, vol. 59, no. 2, pp. 633-641, 2017.
A. Xu, Kouznetsova, V. L., and Tsigelny, I. F., “Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.”, J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
M. Levy Nogueira, Samri, D., Epelbaum, S., Lista, S., Suppa, P., Spies, L., Hampel, H., Dubois, B., and Teichmann, M., “Alzheimer's Disease Diagnosis Relies on a Twofold Clinical-Biological Algorithm: Three Memory Clinic Case Reports.”, J Alzheimers Dis, vol. 60, no. 2, pp. 577-583, 2017.
E. Ruiz, Ramírez, J., Górriz, J. Manuel, and Casillas, J., “Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.”, J Alzheimers Dis, vol. 65, no. 3, pp. 819-842, 2018.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., “Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.”, J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
P. L. McGeer, Guo, J. Ping, Lee, M., Kennedy, K., and McGeer, E. G., “Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1219-1222, 2018.

Pages